- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Degarelix – March 2017
Degarelix: Powder for injection 80 mg (as acetate), injection set, Powder for injection 120 mg (as acetate), injection set; Firmagon®
Last updated
30 June 2017
